Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion "MITI-IA"

Terminated

Phase 2 Results N/A

Summary of Purpose

The purpose of the trial is to evaluate the safety of microplasmin as well as its ability to open blocked arteries to the brain in patients with acute stroke when given into the artery at the site of the blockage. Trial Stopped: Sponsor's decision not to pursue development of uPLi for vascular conditions.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2014.

1 Dec 2006 21 Jul 2005 1 Jul 2007 1 Aug 2008 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available